3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
36
Neoplasms
32
Prostatic Neoplasms
26
Colorectal Neoplasms
25
Lung Neoplasms
21
Carcinoma, Non-Small-Cell Lung
16
Hematologic Neoplasms
13
Neoplasm Metastasis
10
Pancreatic Neoplasms
9
Ovarian Neoplasms
8
Multiple Myeloma
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Triple Negative Breast Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Hematopoietic and Lymphatic System Neoplasm
7
Stomach Neoplasms
6
Carcinoma, Renal Cell
6
Anatomic Stage I Breast Cancer AJCC v8
6
Uterine Cervical Neoplasms
5
Sarcoma
5
Glioma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Gastrointestinal Neoplasms
4
Interventions
Nivolumab
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Cisplatin
4
pembrolizumab
3
cabozantinib
3
avelumab
3
Ipilimumab
3
Carboplatin
3
CTLA-4 Antigen
3
enfortumab vedotin
2
Immunoglobulin G
2
Disulfides
2
Biopsy
2
tremelimumab
1
trastuzumab deruxtecan
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Propranolol
1
Platinum
1
Leucovorin
1
Lenalidomide
1
Fluorouracil
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
Standard of Care
×
1 year
×
Clear all
No trials found.